NASDAQ$COO

The Cooper Companies Inc · Q2 2021 earnings

Q2 2021 earnings · · Investor relations

Briefing

CooperCompanies reported record quarterly earnings driven by strong performance in both CooperVision and CooperSurgical.

CooperCompanies announced strong second-quarter results with revenue up 37% year-over-year to $719.5 million. Both CooperVision and CooperSurgical posted all-time record quarterly revenues, driving record quarterly earnings. The company has updated its fiscal year 2021 financial guidance.

  • Revenue increased 37% year-over-year to $719.5 million.
  • CooperVision revenue was up 30% to $522.6 million.
  • CooperSurgical revenue was up 60% to $196.9 million.
  • Non-GAAP diluted earnings per share were $3.38, up 123% from last year's second quarter.

Headline financials

Total Revenue

$720M

Previous: $525M+37.1%
EPS (adj)

$0.85

Previous: $0.38+123.7%
GAAP Gross Margin

68.0%

Previous: 62.0%+9.7%
GAAP Operating Margin

20.0%

Previous: 5.0%+300.0%
Capital Expenditures

-$106M

Previous: -$158M+33.2%
Free Cash Flow

$235M

Previous: -$2.8M+8475.0%
Net Income

$118M

Previous: $11.5M+921.7%
Operating Income

$143M

Previous: $28.6M+400.7%
Gross Profit

$487M

Previous: $324M+50.6%
Cash & Equivalents

$106M

Previous: $79.8M+32.7%
Total Assets

$9.01B

Previous: $6.51B+38.5%

Revenue & EPS history

Cooper · Revenue · Quarterly

$720M

Q2 2021+37.1%vs Q2 2020
Beat estimate in 12 of 16 quarters(75%)
ActualEstimate

Revenue by segment

Cooper · $197M total across 2 segments · Q2 2021

  • Office and Surgical
    $113M+61.8%
  • Fertility
    $84.3M+58.8%

Forward guidance

The company has updated its fiscal year 2021 financial guidance.

Tailwinds

  • Fiscal 2021 total revenue $2,855 - $2,885 million (14% to 15% constant currency)
  • CVI revenue $2,110 - $2,130 million (11% to 12% constant currency)
  • CSI revenue $745 - $755 million (25% to 27% constant currency)
  • Fiscal 2021 non-GAAP diluted EPS $13.20 - $13.40

Headwinds

  • Resurgences of COVID-19 are viewed as a significant risk factor to the outlook.
  • Inherent difficulty in forecasting acquisition-related, integration and restructuring charges and expenses.
  • Unknown effect, timing and potential significance of such charges and expenses that impact GAAP diluted earnings per share.
  • Adverse changes in the global or regional general business, political and economic conditions
  • Foreign currency exchange rate and interest rate fluctuations

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q2 2021

Historical avgQ2 2021

+0.6%

Avg return

Earnings day

-0.3%

Avg return

5 days after

-0.1%

Avg return

30 days after

52%

36 / 69 earnings

Positive

+12.1%

Q3 2024

Best reaction

-12.8%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2026+10.3%+9.7%
Q1 2026-4.6%-8.0%-12.5%
Q4 2025-4.3%+4.8%+5.3%
Q3 2025-12.8%-11.8%-8.9%
Q2 2025+0.0%-0.3%+3.6%
Q1 2025-6.6%-13.1%-18.9%
Q4 2024-6.0%-5.6%-12.6%
Q3 2024+12.1%+12.1%+16.4%
Q2 2024+3.5%+3.8%-4.2%
Q1 2024+8.1%+7.3%+7.4%
Q4 2023-2.2%-0.7%+6.8%
Q3 2023-2.1%-3.5%-15.9%
Q2 2023-4.0%-5.1%+3.2%
Q1 2023+8.7%+3.9%+15.4%
Q4 2022-1.6%+4.8%+9.7%
Q3 2022+4.1%+2.5%-8.5%
Q2 2022-0.3%+1.3%-7.2%
Q1 2022+2.1%-8.5%+3.1%
Q4 2021+4.8%+8.7%+12.2%
Q3 2021+1.1%-0.7%-7.6%
Q2 2021-0.7%-3.2%+6.0%
Q1 2021+1.8%+0.3%+1.1%
Q4 2020+3.3%+3.3%+8.6%
Q3 2020+2.0%+0.3%+5.7%
Q2 2020-0.2%-5.0%-9.1%
Q1 2020-1.3%-0.9%-17.3%
Q4 2019-1.6%-2.4%+3.3%
Q3 2019-3.5%-6.7%-8.3%
Q2 2019+4.5%+9.0%+18.2%
Q1 2019-1.8%+0.1%+1.0%
Q4 2018-11.6%-7.3%-10.4%
Q3 2018-3.7%-3.4%+4.3%
Q2 2018+1.4%-0.4%+6.0%
Q1 2018+2.1%-3.8%-11.5%
Q4 2017-3.2%-1.9%-1.5%
Q3 2017-4.0%-2.5%-3.7%
Q2 2017+8.9%+10.5%+9.4%
Q1 2017-3.1%-3.6%-0.4%
Q4 2016+1.3%+4.1%+5.2%
Q3 2016+0.0%+1.3%-3.6%
Q2 2016-0.1%-0.4%+7.1%
Q1 2016+6.4%
Q4 2015-12.8%
Q3 2015-7.1%
Q2 2015-5.1%
Q1 2015+9.7%
Q4 2014-4.4%
Q3 2014+0.7%
Q2 2014+1.7%
Q1 2014+4.3%
Q4 2013-4.6%
Q3 2013-1.8%
Q2 2013+8.1%
Q1 2013+2.5%
Q4 2012+1.0%
Q3 2012+10.3%
Q2 2012-4.1%
Q1 2012+2.8%
Q4 2008+2.8%
Q4 2011+2.8%
Q3 2011-1.8%
Q2 2011+1.4%
Q2 2010+1.4%
Q1 2010+8.9%
Q1 2011+1.0%
Q4 2010-1.5%
Q3 2010+5.8%
Q4 2009+5.8%
Q3 2009+5.8%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro